| Patents for C07D 241 - Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings (18,673) |
|---|
| 06/24/2010 | CA2744888A1 Cysteine protease inhibitors |
| 06/23/2010 | EP2199282A1 Amide compound |
| 06/23/2010 | EP2198866A1 Use of ranolazine for the preparation of a medicament for the treatment of arrhythmias |
| 06/23/2010 | EP2197855A1 Heterocyclic scaffolds useful for preparation of combinatorial libraries, libraries and methods of preparation thereof |
| 06/23/2010 | EP2197854A1 A new class of histone deacetylase inhibitors |
| 06/23/2010 | EP2197851A1 Derivatives of n-phenylacetamide as inhibitors of the enzyme soat1 for pharmaceutical and cosmetic use |
| 06/23/2010 | EP2197832A1 Novel aryl potassium channel blockers and uses thereof |
| 06/23/2010 | EP2197830A2 Method for producing amines from sugar alcohols |
| 06/23/2010 | CN101754957A Novel heterocyclyl compounds and their use as chemokine antagonists |
| 06/23/2010 | CN101307025B Chuanxiong alcohol carnitine ester compounds |
| 06/23/2010 | CN101072762B Phenyl-piperazin methanone derivatives |
| 06/22/2010 | US7741519 Bis-aryl sulfonamides |
| 06/22/2010 | US7741328 Treating inflammatory diseases such as rheumatoid arthritis, multiple sclerosis or Crohn's disease; Very Late Antigen-4 (VLA-4), also called alpha 4 beta 1 integrin; N-(sulfonamido-substituted pyrimidyl, pyridyl or pyrazyl)-L-4-(N,N-dimethylcarbamyloxy)phenylalanine compounds |
| 06/22/2010 | US7741325 Benzo[b]chromeno-naphthyridin-7-one and pyrano[2′,3′:7,8]quino[2,3-b]quinoxalin-7-one compounds |
| 06/22/2010 | CA2233550C Symmetrical bis-heteroarylmethoxyphenylalkyl carboxylates as inhibitors of leukotriene biosynthesis |
| 06/17/2010 | WO2010067078A2 3,6-disubstituted xanthylium salts as medicaments |
| 06/17/2010 | US20100152407 Novel compounds |
| 06/17/2010 | US20100152201 Oligomer-Antihistamine Conjugates |
| 06/17/2010 | US20100152138 Cyclic amine bace-1 inhibitors having a benzamide substituent |
| 06/17/2010 | US20100152098 Polybasic bacterial efflux pump inhibitors and therapeutic uses thereof |
| 06/17/2010 | US20100152047 Piperazine Compounds Whith a Herbicidal Action |
| 06/17/2010 | CA2745203A1 3,6-disubstituted xanthylium salts |
| 06/16/2010 | EP2195328A1 Certain chemical entities, compositions, and methods |
| 06/16/2010 | CN1787996B Nitrogen-containing heterocyclic derivatives and drugs containing the same as the active ingredient |
| 06/16/2010 | CN101735158A Preparation method of 2,3-dimercapto-6-methylquinoxaline |
| 06/15/2010 | US7737152 6-carboaryl-oxy-pyrazin-2-yl-carboaryl-amines and compositions comprising said compounds |
| 06/15/2010 | US7737145 Diamine derivatives as inhibitors of leukotriene A4 hydrolase |
| 06/15/2010 | US7737143 such as 6-(1H-Benzimidazol-1-yl)-N-benzylpyrazin-2-amine, used as antidiabetic, anticarcinogenic and antiarthritic agents or for treating autoimmune diseases |
| 06/15/2010 | US7737142 (Thio) carbamoyl-cyclohexane derivatives as D3/D2 receptor antagonists |
| 06/15/2010 | US7736707 lyotropic liquid crystals comprising acenaphtho[1,2-b]quinoxaline derivatives, used to form durable thin films that hardly generates cracks even when the film is exposed under a high-temperature and high-humidity environment |
| 06/15/2010 | CA2521647C Novel hydroxamates as therapeutic agents |
| 06/10/2010 | WO2010032875A3 Heterocyclic carboxamide compounds |
| 06/10/2010 | WO2010025370A3 Preparation of ranolazine |
| 06/10/2010 | US20100145049 Process for making n-(diphenylmethyl)piperazines |
| 06/10/2010 | US20100144759 Novel n-(fluoro-pyrazinyl)-phenylsulfonamides as modulators of chemokine receptor ccr4 |
| 06/10/2010 | US20100144747 1h-quinaz0line-2,4-diones |
| 06/10/2010 | US20100144720 Inhibitors of human tumor-expressed ccxckr2 |
| 06/10/2010 | US20100144661 Sodium channel blockers |
| 06/10/2010 | US20100143805 Nitroxides for lithium-ion batteries |
| 06/10/2010 | US20100143338 Treatment of t-cell mediated diseases |
| 06/10/2010 | US20100141130 Quinoxaline derivative, and light-emitting element, light-emitting device, electronic device using the quinoxaline derivative |
| 06/09/2010 | EP1497273B1 Hydroxamic acid derivatives |
| 06/09/2010 | EP1335907B1 Piperazinylpyrazine compounds as agonist or antagonist of serotonin 5ht-2 receptor |
| 06/09/2010 | EP1292308B1 Alpha,beta-unsaturated sulfones for treating proliferative disorders |
| 06/09/2010 | CN101724099A Aromatic ketone compound and photoinitiator with same |
| 06/09/2010 | CN101723908A Method for preparing di-nitrogen quinoxalin compound |
| 06/09/2010 | CN101723907A O-dicyano-acenaphtho pyrazine compound and anti-tumor application thereof |
| 06/09/2010 | CN101215299B Quinoxalines ligand iridium complexes and synthetic method thereof |
| 06/08/2010 | US7732605 inducing cyclization of an alpha -keto acid with an acid catalyst; N-2-oxo-propanoyl-L-phenylalanine amide; antitumor activity and selectivity |
| 06/08/2010 | US7732375 anilide fungicides such as 1,3,5-trimethyl-N-[2-(1,3,3-trimethylbutyl)phenyl]-1H-pyrazole-4-carboxamide, used for controlling unwanted microorganisms |
| 06/08/2010 | US7731940 N-(2-[4-(2-methoxyphenyl)piperazinyl]ethyl)-N-(2-pyridyl)-N-(4-18F-fluoro-methylcyclohexane)carboxamide, used for treating panic, bipolar or seizure disorders, and as a quantitative tool for measuring serotonin concentration in the brain |
| 06/03/2010 | WO2010062107A1 Organic electroluminscent device using electroluminescent compounds |
| 06/03/2010 | WO2010030891A3 Aryl guanidine f1f0-atpase inhibitors and related methods |
| 06/03/2010 | WO2010009210A3 Acetylsalicyclic acid derivatives useful to treat metabolic syndromes |
| 06/03/2010 | US20100137595 Vaginal odorants |
| 06/03/2010 | US20100137583 Peptidomimetic protease inhibitors |
| 06/03/2010 | US20100137336 Novel amido derivatives and their use as positive allosteric modulators of metabotropic glutamate receptors |
| 06/03/2010 | US20100137328 Tricyclic anilide heterocyclic cgrp receptor antagonists |
| 06/03/2010 | US20100137307 Novel 1,2,3,4,-tetrahydroquinoxaline derivative which has, as substituent, phenyl group having sulfonic acid ester structure or sulfonic acid amide structure introduced terein and has glucocorticoid receptor-binding activity |
| 06/03/2010 | US20100137290 Oxazolidinone antibiotic derivatives |
| 06/03/2010 | US20100137288 Indazoles, benzothiazoles, benzoisothiazoles, benzisoxazoles, pyrazolopyridines, isothiazolopyridines, and preparation and uses thereof |
| 06/03/2010 | US20100137194 Plasminogen Activator Inhibitor-1 Inhibitors and Methods of Use Thereof to Modulate Lipid Metabolism |
| 06/03/2010 | US20100135999 Quinoline-carboxamide derivatives as p2y12 antagonists |
| 06/03/2010 | US20100133519 Arylamine compounds and electronic devices |
| 06/02/2010 | EP2192117A1 Organic amine salt of 6-fluoro-3-hydroxy-2-pyrazinecarbonitrile and method for producing the same |
| 06/02/2010 | EP2190827A1 N-benzyl, n' -arylcarbonylpiperazine derivatives as lxr modulators |
| 06/02/2010 | EP1483228B1 Nk1 antagonists |
| 06/01/2010 | US7728009 such as 1-{[2-(2,3-dimethylphenyl)-4- methyl-1,3-thiazol-5-yl]carbonyl}- 4-isopropylpiperazine, used to modulate ligand binding to histamine H3 receptors in vivo or in vitro, and particularly useful in the treatment of central nervous system disorders in humans |
| 06/01/2010 | US7728007 Therapeutic amides |
| 06/01/2010 | US7727997 N,N′-substituted-1,3-diamino-2-hydroxypropane derivatives |
| 06/01/2010 | US7727750 Biocatalytic asymmetric reduction in preparation of (S)-N-[5-(1,2-dihydroxy-ethyl)-pyrazinyl]-2,2-dimethyl-propionamide |
| 05/27/2010 | WO2010058995A1 Electroluminescent device using the electroluminescent compounds |
| 05/27/2010 | WO2010019911A3 1,4-benzoxazine compounds and derivatives thereof as therapeutic drugs for the treatment of neurodegenerative conditions |
| 05/27/2010 | US20100130739 Nitrogen-containing six-membered aromatic ring derivatives and pharmaceutical products containing the same |
| 05/27/2010 | US20100130737 Regulating Agent of GPR34 Receptor Function |
| 05/27/2010 | US20100130484 Novel bicyclic sulfonamide derivatives which are l-cpt1 inhibitors |
| 05/27/2010 | US20100130447 Inhibitors of kinase activity |
| 05/26/2010 | EP2188268A1 Substituted piperazinyl pyrazines and pyridines as 5-ht7 receptor antagonists |
| 05/26/2010 | EP2188267A2 Substituted amides, methods of making, use thereof for the treatment of diseases such as cancer |
| 05/26/2010 | EP2188266A2 Novel piperazine amide derivatives |
| 05/26/2010 | CN1949966B Quinoxalin-2-one derivatives, crop protection agents comprising the same and method for production and use therof |
| 05/26/2010 | CN1391469B Npyy5拮抗剂 Npyy5 antagonist |
| 05/26/2010 | CN101712657A heteroarylcarbamoylbenzene derivative |
| 05/26/2010 | CN101712655A Acetamide derivative and application thereof in pharmacy |
| 05/26/2010 | CN101712646A Alkoxyamines containing a radically polymerizable group |
| 05/26/2010 | CN101058564B Aryl alkyl carbamate derivatives production and use thereof in therapy |
| 05/25/2010 | US7723519 high binding efficiencies between D3 and D2 dopaminergic receptor subtypes; drug abuse, drug dependence |
| 05/25/2010 | US7723362 for controlling acarina |
| 05/25/2010 | US7723349 N-hydroxy-5-methyl-6-{[4-(3-methylphenyl)piperazin-1-yl]carbonyl}-5-azaspiro[2.5]octane-7-carboxamide for example; treating arthritis, cancer, cardiovascular disorders, skin disorders, inflammation and allergic conditions |
| 05/25/2010 | US7723338 Crystalline forms of 1-benzoyl-4-[2-[4,7-dimethoxy-1-[(phosphonooxy)methyl]-1H-pyrrolo[2,3-C]pyridin-3-yl]-1,2-dioxoethyl]-piperazine |
| 05/25/2010 | US7723337 3-cinnolinecarboxamide derivatives and their use for treating cancer |
| 05/25/2010 | US7723082 Polynucleotides and polypeptides coded by said polynucleotides involved in the synthesis of diketopiperazine derivatives |
| 05/25/2010 | CA2248303C Perfluorinated amide salts and their uses as ionic conducting materials |
| 05/20/2010 | WO2010055884A1 Method for producing pyrazine derivative and intermediate thereof |
| 05/20/2010 | US20100125077 Polymorphs of Brimonidine Pamoate |
| 05/20/2010 | US20100125075 Antibacterial Agents |
| 05/20/2010 | US20100125061 Naphthylacetic acids |
| 05/20/2010 | US20100125058 Naphthylacetic acids |
| 05/20/2010 | DE102008058230A1 New quinoxaline compound, useful in organic solar cells as an exciton blocker or electron transport layer and in organic light-emitting diodes as an electron transport layer or emitter matrix |
| 05/19/2010 | EP2185561A2 1,2,3,4-tetrahydropyrroloý1,2-a¨pyrazine-6-carboxamide and 2,3,4,5-tetrahydropyrroloý1,2-a¨ý1,4¨-diazépine-7-carboxamide derivatives, preparation and therapeutic use thereof |